HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G FISCAL 1995 FIRST QUARTER NET EARNINGS ADVANCE 18.2% TO $792 MIL.

This article was originally published in The Rose Sheet

Executive Summary

P&G FISCAL 1995 FIRST QUARTER NET EARNINGS ADVANCE 18.2% TO $792 MIL. on a sales increase of 7.9% to $8.16 bil., the company said in an Oct. 26 statement of sales and earnings for the quarter ended Sept. 30. According to Procter & Gamble Chairman and CEO Edwin Artzt, "The earnings improvement reflects strong worldwide unit volume growth and good cost control throughout the company." First quarter worldwide unit volume grew 10%, three percentage points of which was associated with acquisitions net of divestitures, compared to a 5% increase in fiscal 1994.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000991

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel